| Host: |
HEK293 cells |
| Reactivity: |
SARS-COV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike RBD-C-His & Avi protein was developed from hek293 cells and has a target region of C-His & Avi. For use in research applications. |
| Conjugation: |
Biotin |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Immobilized Human ACE2, His Tag at 2 Mu g/mL (100 Mu L/Well) on the plate. Dose response curve for Biotinylated SARS COV-2 Spike RBD, His Tag with the EC50 of 0.097 Mu g/mL determined by ELISA. |
| Immunogen Region: |
Arg319-Asn532 |
| Immunogen: |
Biotinylated Recombinant SARS-COV-2 SARS-COV-2 Spike RBD Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Arg319-Asn532) of SARS-COV-2 SARS-COV-2 Spike RBD fused with His tag and Avi at the C-terminal. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
